Ticker Symbol: PRQR
ProQR Therapeutics N.V
$7.87 - 02-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
Netherlands
Currency:
USD
Asset
Type: Common Stock
CIK:0001612940
Company Profile
ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA therapies for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis pigmentosa. Based on its unique proprietary RNA repair platform technologies, the Company is growing its pipeline with patients and loved ones in mind.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: Zernikedreef 9
Website: www.proqr.com
CEO: Daniel De Boer
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.44
Change:
$0.19
(
15.20%)
Days Range: $1.18 - $1.58
Beta: 0.21
52wk. High: $3.85
52wk. Low: $0.84
Ytd. Change -51.02%
50 Day Moving Average: $1.42
200 Day Moving Average: $1.71
Shares Outstanding: 80817079
Valuation
Market Cap: 11.6B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A